Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Opioid deprescribing is advised when risks of opioid use outweigh benefits. A tailored, patient-centered plan with gradual dose reduction, monitoring, and support can improve outcomes and reduce harm.

Approximately 5 million persons in the United States have psoriasis.1 Most have mild disease covering less than 3% of body-surface area, but approximately one fifth have more extensive involvement ...